Invesco
NAUT icon

Invesco’s Nautilus Biotechnolgy NAUT Stock Holding History

Invesco’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.8K Buy
+35,200
New +$92.9K ﹤0.01% 3775
2025
Q2 		– Sell
-17,101
Closed -$14.7K – 3830
2025
Q1 		$14.7K Sell
17,101
-780
-4% -$1.16K ﹤0.01% 3752
2024
Q4 		$30K Sell
17,881
-2,739
-13% -$6.55K ﹤0.01% 3730
2024
Q3 		$58.8K Sell
20,620
-625
-3% -$1.62K ﹤0.01% 3669
2024
Q2 		$49.7K Sell
21,245
-1,817
-8% -$4.74K ﹤0.01% 3823
2024
Q1 		$67.8K Buy
23,062
+350
+2% +$993 ﹤0.01% 3781
2023
Q4 		$67.9K Buy
22,712
+5,010
+28% +$14.3K ﹤0.01% 3728
2023
Q3 		$55.9K Buy
17,702
+67
+0.4% +$218 ﹤0.01% 3787
2023
Q2 		$68.2K Sell
17,635
-288
-2% -$830 ﹤0.01% 3786
2023
Q1 		$49.6K Sell
17,923
-1,123
-6% -$2.36K ﹤0.01% 3758
2022
Q4 		$34.3K Sell
19,046
-193
-1% -$373 ﹤0.01% 3938
2022
Q3 		$41K Sell
19,239
-169
-0.9% -$425 ﹤0.01% 3931
2022
Q2 		$52K Buy
+19,408
New +$72.2K ﹤0.01% 3965

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Invesco's NAUT Position: Q2 2026 in Review

Invesco opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 35,200 shares worth $65.8K. The stake represents ﹤0.01% of the portfolio and ranks #3775 among its holdings. This is a return to the name: Invesco previously reported a position in NAUT as recently as Q1 2025.

Invesco first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $68.2K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Invesco held 35,200 shares of Nautilus Biotechnolgy worth $65.8K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Invesco position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3775 holding.
  • Invesco first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
  • Invesco's Nautilus Biotechnolgy position peaked at $68.2K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.